The following pages link to Modestly weighted logrank tests (Q6625167):
Displaying 5 items.
- Cancer immunotherapy trial design with random delayed treatment effect and cure rate (Q6622287) (← links)
- M\&M: a maximum duration design with the MaxCombo test for a group sequential trial of an immunotherapy with a random delayed treatment effect (Q6622292) (← links)
- New late-emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials (Q6625734) (← links)
- On information fraction for Fleming-Harrington type weighted log-rank tests in a group-sequential clinical trial design (Q6627777) (← links)
- Window mean survival time (Q6628242) (← links)